Recommendations for screening, treatment, and management of lupus nephritis: New ACR guideline summary Dr. Kamal Kant Kohli2 Dec 2024 4:14 PM ISTWashington: During ACR Convergence 2024, the American College of Rheumatology (ACR) unveiled a summary of the 2024 Guideline for the Screening,...
Belimumab initiation may help lupus patients reduce their reliance on oral corticosteroids Medha Baranwal18 Jan 2024 7:00 PM ISTUSA: Findings from a new trial have provided more real-world evidence for belimumab's steroid-sparing effect, showing significant reductions in oral...
USFDA grants Orphan Drug Designation to GSK Benlysta for systemic sclerosis Ruchika Sharma2 Feb 2023 1:15 PM ISTSystemic sclerosis (SSc) is a rare autoimmune disease that causes atypical growth of connective tissues and can affect the musculoskeletal system,...
Belimumab improves cutaneous lupus erythematosus in patients with or without SLE Dr. Kamal Kant Kohli29 Nov 2022 8:00 PM ISTNew research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that the B-cell inhibitor...
Belimumab therapy provides better outcome in patients with Cutaneous Lupus Erythematosus Jacinthlyn Sylvia25 Nov 2022 7:45 AM ISTA new study conducted by Rachel Kneeland and team shows that significant belimumab-induced cutaneous clinical responses (44%–55%) and a 50% reduction...
GSK gets USFDA nod for Benlysta for children with active lupus nephritis Ruchika Sharma29 July 2022 11:39 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (USFDA) has approved Benlysta (belimumab) for the treatment of children aged 5...
FDA approves belimumab for lupus nephritis for pediatric patients Dr. Kamal Kant Kohli28 July 2022 10:15 AM ISTThe FDA has approved belimumab for the treatment of active lupus nephritis for children who are also receiving standard therapy. The drug is being...
GSK proposal for marketing Belimumab rejected by CDSCO panel Medical Dialogues Team8 July 2021 6:31 PM ISTNew Delhi: In a major setback to GlaxoSmithKline (GSK) Pharmaceuticals, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
GSK gets EMA panel recommendation to approve Benlysta for adult patients with active lupus nephritis Ruchika Sharma29 March 2021 9:30 AM ISTUK: GlaxoSmithKline plc (GSK) has recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
Belimumab add on improves renal response in lupus nephritis patients: NEJM Medha Baranwal2 Nov 2020 4:30 PM ISTUSA: The addition of belimumab to standard therapy improved renal outcomes in patients with lupus nephritis, according to a recent study in the New...
Belimumab addition to standard therapy improves results in lupus Nephritis: NEJM Dr Satabdi Saha21 Sept 2020 10:00 AM ISTLupus nephritis, which occurs in 25 to 60% of patients with systemic lupus erythematosus (SLE), is the most common severe manifestation of SLE and a...
